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Background: Malignant triton tumors are relatively rare and highly aggressive tumors in which malignant
schwannoma cells coexist with rhabdomyoblasts. Their occurrence in the retroperitoneum is uncommon and has
been rarely reported.
Case presentation: We present the case of a patient with a retroperitoneal malignant triton tumor. A 32-year-old
male was referred with epigastric pain and an abdominal mass. Computed tomography revealed a huge soft tissue
retroperitoneal mass that involved adjacent organs and vessels. Complete resection was undertaken. Pathological
examination confirmed the presence of a malignant triton tumor. The patient died two and a half months after
surgery, as a result of local recurrence.
Conclusion: Malignant triton tumors are uncommon sarcomas that are associated with a high incidence of
developing local recurrence and distant metastases. Immunohistochemical staining showing nerve sheath
differentiation with rhabdomyoblastic cells confirms the diagnosis. Complete excision of the tumor is the most
effective treatment strategy for these retroperitoneal tumors.
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Malignant triton tumor (MTT) is a relatively rare sub-
type of malignant peripheral nerve sheath tumors
(MPNST), histologically defined as a malignant periph-
eral nerve sheath tumor with additional rhabdomyoblas-
tic differentiation. MTTs are usually located in the head,
neck, extremities and trunk [1]. Less common sites in-
clude the buttock, the mediastinum and the retroperito-
neum [2]. Tumors in the retroperitoneum, however, are
extremely rare, and fewer than 10 cases have been
reported since 1984 [1,3-8]. We present the case of a
retroperitoneal MTT in a 32-year-old male patient, and
review all published clinical reports of this tumor to
date.* Correspondence: shusenzheng@zju.edu.cn
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A 32-year-old male, previously fit and healthy, presented
with epigastric pain and was found to have an abdominal
mass on abdominal ultrasound. He was referred to the
First Affiliated Hospital, School of Medicine, Zhejiang
University for further investigation and treatment in Oc-
tober 2010. There were no signs of neurofibromatosis
type 1(NF-1). Physical examination revealed a firm, ill-
defined, fixed mass in the upper abdomen. Laboratory
findings, including leukocyte and platelet counts,
hemoglobin, serum creatinine, liver function, alpha-feto-
protein, carcinoembryonic antigen and cancer antigen
19–9, were all within normal limits.
Contrast-enhanced computed tomography (CT) of the
chest and abdomen showed a heterogeneous tissue
retroperitoneal mass, approximately 16 cm in diameter
(Figure 1). Following contrast, heterogeneous enhance-
ment of the mass was noted. Adjacent vessels, such as
the common hepatic artery, the portal vein and the in-
ferior vena cava, were compressed. There was no evi-
dence of associated lymphadenopathy or distant
metastases. Biopsy of the tumor suggested a soft tissue
sarcoma composed of pleomorphic spindle cells.his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Abdominal computed tomography showing a huge tumor occupying the entire retroperitoneal space.
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cated that surgery was feasible. At surgery, a huge, soft,
whitish, solid and cystic tumor was found, which occu-
pied the entire abdomen. The tumor appeared to involve
the distal stomach, the diaphragm, the hepatoduodenal
ligament, the gastrohepatic ligament, the left lobe of the
liver and the celiac trunk. It was also compressing the
walls of the abdominal aorta and the inferior vena cava.
Massive varicose veins were noted in the abdominal cav-
ity. Part of the left lobe of the liver was resected due to
tumor infiltration. A distal gastrectomy with a Billroth II
anastomosis was simultaneously performed due to
tumor involvement of the stomach. In addition, we sus-
pected that the common bile duct had also been invaded
by tumor, which was not evident on preoperative im-
aging, and we therefore performed a resection of the
common bile duct, a cholecystectomy and T-tube drain-
age. Intraoperative histological examination of a frozen
section suggested the presence of a soft tissue sarcoma.
On gross examination, the tumor measured
16 × 15.5 × 8.2 cm. The cut surface appeared firm and
yellowish in the peripheral portion with foci of
hemorrhage and excessive necrosis in the center. The
margins appeared macroscopically clear.
On further histopathological examination, the neoplas-
tic tissue displayed interlacing fascicles of spindle cells
with wavy, elongated hyperchromatic nuclei. There was
pronounced pleomorphism, an increased mitotic index
(>50 mitoses per 10 high-power fields) and hypercellu-
larity. Rhabdomyosarcomatous differentiation was evi-
denced by foci of scattered, round cells with a
prominent eosinophilic cytoplasm and atypical nuclei,
which were identified as rhabdomyoblasts (Figure 2).
Microscopically, the margins were confirmed to be clear
of residual tumor.Immunohistochemistry demonstrated positive staining
of the rhabdomyoblastic cells for desmin (Figure 3A)
and vimentin. Nerve sheath differentiation of the spindle
cells was confirmed by S-100 protein (Figure 3B) positiv-
ity. Tumor tissue was negative for smooth muscle actin,
HMB-45, CD34 and CD117. Based on these findings,
the diagnosis of a MTT was confirmed.
According to the Fédération Nationale des Centres de
Lutte Contre le Cancer (FNCLCC) grading system [9],
the tumor was classified as grade 3 (a total score of 7: 3
for malignant triton tumor, 3 for >50 mitoses per 10
high-power fields and 1 for <50% tumor necrosis). The
surgical margins were estimated as wide [10]. As no
macroscopic or microscopic tumor remained, surgical
resection was judged complete.
Following surgery, the patient made a good recovery
and was discharged two weeks later. However, during
his first follow-up assessment one month after surgery,
CT imaging revealed multiple lesions in the liver, which
were considered a recurrence of the tumor. Clinical de-
terioration occurred rapidly, and no subsequent treat-
ment was undertaken. The patient died two and a half
months after the operation.
Discussion
Rhabdomyosarcomatous elements within MPNSTs were
first described by Masson in patients with neurofibroma-
tosis [11]. The name triton was first used by Woodruff
et al. [12] on the basis of the discovery that supernumer-
ary limbs containing neural and muscular elements were
induced to grow on the backs of triton salamanders by
transplantation. Woodruff et al. [12] also proposed three
criteria for determining whether a neoplasm could be
truly classified as a malignant ‘Triton’ tumor or not: one,
arises from a peripheral nerve, or in a patient with NF-1,
Figure 2 Images of HE staining showing typical malignant schwannoma cells and rhabdomyoblasts. Large pleomorphic
rhabdomyoblastic cells with abundant eosinophilic cytoplasm are embedded in a spindle cell tumor with a fine fibrillary matrix. (Original
magnification 400×).
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represents a metastasis from such tumor; two, demon-
strates the growth characteristics of Schwann cells; and
three. contains bona fide rhabdomyoblasts that appear
to arise from within the body of the peripheral nerve
tumor and which cannot be attributed to either an ex-
tension or metastasis from an extrinsic rhabdomyosar-
coma. Daimaru et al. [13] later suggested broadening the
definition to include the following: one, tumors in
patients without NF-1 that are microscopically compat-
ible with a malignant schwannoma and contain focal
rhabdomyoblasts; and two, tumors consisting predomin-
antly of rhabdomyoblastic differentiation with focal
Schwann cell elements occurring within a nerve or in
patients with NF-1. Today, the diagnosis of MTT is gen-
erally made according to these criteria, as well as on
immunohistochemistry findings [14]. The presence of
positive immunoreactivity to S-100 protein or Leu-7Figure 3 Immunohistochemical features of desmin and S-100 staining
desmin (A) and S-100 (B). (Original magnification 400×).indicates nerve sheath differentiation, while rhabdomyo-
blastic cells have a positive immunoreactivity to desmin,
muscle specific actin, myosin, vimentin, and myoglobu-
lin [2,12,14]. In our case, we identified typical malignant
schwannoma cells and rhabdomyoblasts. Furthermore,
immunohistochemistry was positive for desmin, vimen-
tin and S-100 protein, confirming the diagnosis of MTT.
Epidemiologically, the mean age of patients with MTT
has been estimated to be 31.7 years [2,4], although the
disease may affect anyone between the ages of 0 and
81 years. There appears to be an equal sex distribution
in those affected, and the tumor coexists with NF-1 in
44% to 69% of cases. When associated with NF-1, MTT
tends to present at a younger age and in males, than has
been observed in sporadic cases. MTT is a highly ag-
gressive tumor with low overall survival rates (estimated
five-year survival rates are 26%) [2] and high rates of
metastases (48%) and local recurrence (43%) [1,12]. Thein the malignant triton tumor (A and B). The mass was positive for
Table 1 Summary of malignant triton tumor cases of the retroperitoneum
Case Sex/Age PastHistory Treatment Tumor
Size
Metastases/Recurrence Follow up
Surgical Resection Chemotherapy Radiotherapy
Ducatman1984 [3] 12/F NF-1 Complete - - N/A Recurrence 2 mo after
surgery
DOD 15 mo
Brooks1985 [1] Congenital/F N/A Incomplete VCR,ACT,CTX 0.9 Gy 9 cm Liver, pleura metastases DOD 3 yr
33/M NF-1 Incomplete ADM ‘large’ Lung metastases DOD 14 mo
Haddadin 2003 [4] 81/M Paget’s
disease of
bone
N/A N/A N/A 15 cm Small and large bowel,
peritoneum metastases
N/A
Rekhi 2008 [8] 23/F - Incomplete +(unspecified) 16 cm No metastasis N/A
Radovanovic,2008 [7] 60/F - Complete - - 7 cm Rectum, lungs, liver, spleen
metastases, local recurrence
1 mo after surgery
DOD 2 mo
Hoshimoto2009 [5] 21/M NF-1 Complete +(unspecified) 19 cm Psoas muscle, thigh, hip
joint, abdominal aorta, lung
metastases
DOD 14 mo
Koutsopoulos2011 [6] 18 F NF-1 Complete IFO,ADM 54 Gy 9.5 cm No metastasis/recurrence ANED >5 yr
Present case 32/M - Complete - - 16 cm Liver, stomach, abdominal aorta metastases DOD 2.5 mo
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of the tumor and the extent of the excision
[1,2,12,13,15]. Patients with head, neck or extremity neo-
plasms survive longer than those with tumors of the but-
tock, trunk or retroperitoneum [2]. Complete resection
appears to be associated with an improved prognosis,
decreased rates of local recurrence and metastasis, and a
better response to adjuvant therapies; however, most
patients with MTTs die even after receiving all available
treatments, usually within months [1,2]. The present
case was a 32-year-old male patient without a history of
NF-1. The tumor was huge (16 cm in diameter) and
located in the retroperitoneum, with involvement of ad-
jacent organs. Despite complete resection, the tumor
progressed and recurred within a month.
To date, approximately 170 cases of MTT have been
reported in the literature worldwide [2,16,17]. Among
these, MTT located in the retroperitoneum is extremely
rare. We found only eight cases reported in the English
literature using MEDLINE. Including the present case,
data from nine patients have been reviewed. The clinical
characteristics of these cases are summarized in Table 1.
All patients presented with a huge retroperitoneal mass,
which ranged from 7 to 19 cm in diameter. The size at
presentation may be explained by the fact that retroperi-
toneal tumors are often asymptomatic in the early stages,
as demonstrated in our case. The presence of a retroperi-
toneal MTT may only be expressed by the insidious
onset of nonspecific and late symptoms, such as vague
abdominal pain due to compression or infiltration of ad-
jacent viscera, vessels, or nerves. Thus retroperitoneal
MTTs are associated with a worse prognosis, higher rates
of metastatic disease and earlier recurrence rates, than
MTTs in the extremities, due to delays in diagnosis, simi-
lar to MPNSTs in the abdominal cavity [7,18]. The pa-
tient we present had a long history of postprandial
abdominal distention and dull pain. Symptoms such as
abdominal pain followed when the tumor had grown,
measuring 16 cm in diameter, at which point it was asso-
ciated with infiltration of adjacent viscera and vessels.
Due to the rarity of MTT, treatment modalities, espe-
cially in advanced and metastatic cases, are not well
established, and there are no standardized management
guidelines. As with many soft tissue sarcomas (STSs),
the most effective therapeutic strategy for retroperiton-
eal MTT is complete resection of the tumor. The status
of the microscopic margins after resection has a signifi-
cant impact on local outcome and survival [10]. Ennek-
ing et al. [10] described four types of margins
histologically: intralesional, marginal, wide and radical.
However, surgical margins are often difficult to define as
metastasis within the abdomen may occur. Furthermore,
the retroperitoneal space is one of the most challenging
sites technically. Anatomic constraints limit the abilityto achieve wide excision in this location, which is un-
likely to be attained in most cases. This creates the chal-
lenge of balancing the need for adequate margins for
optimal tumor control with the need to minimize opera-
tive morbidity and loss of function, similar to other STSs
[19]. In our patient, the primary tumor was huge and
involved adjacent organs. We performed complete resec-
tion with wide margins, at the cost of the excision of
invaded organs, including the liver, stomach, gallbladder
and common bile duct. However, local recurrence still
developed soon after surgery before postoperative treat-
ment could be commenced.
The role of adjuvant therapy, for example radiotherapy
and chemotherapy, is less well defined and has not been
proven to be effective [1,14,15], although it may be of
value in individual patients who have undergone
complete resection [6,20-22]. Several reports suggest
that repeated resection combined with chemotherapy
and/or radiotherapy for recurrent MTTs may prolong
survival [6,20,21]. The only patient with a retroperiton-
eal MTT who experienced long-term survival (>5 years)
in our review was reported to have undergone a
complete resection followed by postoperative radiother-
apy and chemotherapy. Moreover, neoadjuvant chemo-
therapy in MTT has been reported in two patients with
metastatic disease [23], although the number of cases is
too small to allow a definitive conclusion on the effect-
iveness of neoadjuvant chemotherapy.Conclusion
Malignant triton tumors are uncommon sarcomas that
are associated with a high incidence of local recurrence
and distant metastases. Immunohistochemical staining
showing nerve sheath differentiation with rhabdomyo-
blastic cells confirms the diagnosis of MTT. Complete
excision of the tumor is the most effective therapeutic
strategy for retroperitoneal MTTs.Consent
Written informed consent was obtained from the patient
for publication of this case report and the accompanying
images. Copies of the written consent form are available
for review upon request.
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